Pact Pharma, Inc. is a biotechnology company focused on developing personalized cancer treatments using their proprietary technology platform. Their approach involves engineering neoantigen-specific T cells to target and kill cancer cells, with the goal of delivering more effective and targeted therapies for patients with various types of cancer. Pact Pharma is dedicated to advancing precision medicine and transforming the landscape of cancer treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#126 in South San Francisco, CA

#9,508 in California

#39,929 in US

South San Francisco, CA, United States of America

Pact Pharma, Inc.

Forward Citations = 2

13 inventors:

Alex Franzusoff (6 out of 8 patents)

Kyle Jacoby (5 out of 7 patents)

Barbara Sennino (2 out of 8 patents)

4. Stefanie Mandl-Cashman (2 out of 4 patents)

5. Olivier Dalmas (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pact Pharma, Inc.. Retrieved from https://idiyas.com/company/pact-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]